{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:44:36Z","timestamp":1768401876624,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008978","name":"Philips Oral Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008978","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.carrev.2019.12.039","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T06:11:17Z","timestamp":1578377477000},"page":"540-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The Orsiro Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stent: A Review of Current Evidence"],"prefix":"10.1016","volume":"21","author":[{"given":"Brian J.","family":"Forrestal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Case","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charan","family":"Yerasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hector M.","family":"Garcia-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9960","key":"10.1016\/j.carrev.2019.12.039_bb0005","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0140-6736(14)61038-2","article-title":"Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial","volume":"384","author":"Pilgrim","year":"2014","journal-title":"Lancet"},{"issue":"10105","key":"10.1016\/j.carrev.2019.12.039_bb0010","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","article-title":"Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial","volume":"390","author":"Kandzari","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.carrev.2019.12.039_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.001441","article-title":"Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial","volume":"8","author":"Windecker","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.carrev.2019.12.039_bb0020","first-page":"55","article-title":"Performance of the Orsiro hybrid drug-eluting stent in high-risk subgroups","volume":"64","author":"Iglesias","year":"2016","journal-title":"Minerva Cardioangiol"},{"issue":"2","key":"10.1016\/j.carrev.2019.12.039_bb0025","first-page":"142","article-title":"Orsiro - the first hybrid drug-eluting stent, opening up a new class of drug-eluting stents for superior patient outcomes","volume":"6","author":"Tittelbach","year":"2011","journal-title":"Interventional Cardiology Review"},{"issue":"9","key":"10.1016\/j.carrev.2019.12.039_bb0030","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.4244\/EIJV8I9A155","article-title":"Clinical and angiographic experience with a third-generation drug-eluting Orsiro stent in the treatment of single de novo coronary artery lesions (BIOFLOW-I): a prospective, first-in-man study","volume":"8","author":"Hamon","year":"2013","journal-title":"EuroIntervention"},{"issue":"2","key":"10.1016\/j.carrev.2019.12.039_bb0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/CIRCULATIONAHA.104.508937","article-title":"Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents","volume":"112","author":"Finn","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.carrev.2019.12.039_bb0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.carrev.2019.12.039_bb0045","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/eurheartj\/ehp127","article-title":"MAHOROBA, first-in-man study: 6-month results of a biodegradable polymer sustained release tacrolimus-eluting stent in de novo coronary stenoses","volume":"30","author":"Onuma","year":"2009","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.carrev.2019.12.039_bb0050","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jcin.2018.04.014","article-title":"Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: 5-year outcomes of the randomized BIOFLOW-II trial","volume":"11","author":"Lefevre","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.12.039_bb0055","series-title":"BIOFLOW VI -Oral Presentation CIT 2018","volume":"2018","year":"2018"},{"issue":"1","key":"10.1016\/j.carrev.2019.12.039_bb0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.carrev.2019.03.004","article-title":"Five-year results of the BIOFLOW-III registry: real-world experience with a biodegradable polymer sirolimus-eluting stent","volume":"21","author":"Waltenberger","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"issue":"10","key":"10.1016\/j.carrev.2019.12.039_bb0065","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4244\/EIJY15M03_08","article-title":"Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry","volume":"11","author":"Waltenberger","year":"2016","journal-title":"EuroIntervention"},{"issue":"11","key":"10.1016\/j.carrev.2019.12.039_bb0070","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-18-01214","article-title":"BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12\u202fmonths","volume":"15","author":"Saito","year":"2019","journal-title":"EuroIntervention"},{"issue":"17","key":"10.1016\/j.carrev.2019.12.039_bb0075","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.jacc.2018.02.029","article-title":"Pharmacogenomic approach to selecting antiplatelet therapy in patients with acute coronary syndromes: the PHARMCLO trial","volume":"71","author":"Notarangelo","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.carrev.2019.12.039_bb0080","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.amjcard.2019.06.021","article-title":"Efficacy and safety of ultrathin, Bioresorbable-polymer Sirolimus-eluting stents versus thin, durable-polymer Everolimus-eluting stents for coronary revascularization of patients with diabetes mellitus","volume":"124","author":"Waksman","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2019.12.039_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2017.08.001","article-title":"Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach","volume":"193","author":"Doros","year":"2017","journal-title":"Am Heart J"},{"issue":"25","key":"10.1016\/j.carrev.2019.12.039_bb0090","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/j.jacc.2018.09.019","article-title":"Ultrathin bioresorbable polymer sirolimus-eluting stents versus thin durable polymer Everolimus-eluting stents","volume":"72","author":"Kandzari","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2019.12.039_bb0095","author":"United States Food and Drug Administration"},{"issue":"10149","key":"10.1016\/j.carrev.2019.12.039_bb0100","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(18)31715-X","article-title":"Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial","volume":"392","author":"Pilgrim","year":"2018","journal-title":"Lancet"},{"issue":"10060","key":"10.1016\/j.carrev.2019.12.039_bb0105","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0140-6736(16)31920-1","article-title":"Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial","volume":"388","author":"von Birgelen","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.carrev.2019.12.039_bb0110","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4244\/EIJ-D-18-00336","article-title":"Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial","volume":"14","author":"Kok","year":"2018","journal-title":"EuroIntervention"},{"issue":"10154","key":"10.1016\/j.carrev.2019.12.039_bb0115","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0140-6736(18)32001-4","volume":"392","author":"von Birgelen","year":"2018","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.carrev.2019.12.039_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003610","article-title":"Randomized comparison of a biodegradable polymer ultrathin strut sirolimus-eluting stent with a biodegradable polymer biolimus-eluting stent in patients treated with percutaneous coronary intervention: the SORT OUT VII trial","volume":"9","author":"Jensen","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2019.12.039_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2019.02.017","volume":"213","author":"Jensen","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2019.12.039_bb0130","author":"Okkels Jensen"},{"issue":"1 Pt A","key":"10.1016\/j.carrev.2019.12.039_bb0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.carrev.2017.11.009","article-title":"Comparison of the ultrathin Orsiro hybrid sirolimus-eluting stent with contemporary drug-eluting stents: a meta-analysis of randomized controlled trials","volume":"19","author":"Lipinski","year":"2018","journal-title":"Cardiovasc Revasc Med"},{"issue":"10","key":"10.1016\/j.carrev.2019.12.039_bb0140","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.amjcard.2018.07.040","article-title":"Meta-analysis of the impact of strut thickness on outcomes in patients with drug-eluting stents in a coronary artery","volume":"122","author":"Iantorno","year":"2018","journal-title":"Am J Cardiol"},{"issue":"20","key":"10.1016\/j.carrev.2019.12.039_bb0145","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.118.034456","article-title":"Newer-generation ultrathin strut drug-eluting stents versus older second-generation thicker strut drug-eluting stents for coronary artery disease","volume":"138","author":"Bangalore","year":"2018","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.carrev.2019.12.039_bb0150","article-title":"Bioabsorbable polymer everolimus-eluting stents in patients with acute myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry","volume":"14","author":"Sergio","year":"2018","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.carrev.2019.12.039_bb0155","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2217\/fca-2019-0001","article-title":"Orsiro: ultrathin bioabsorbable polymer sirolimus-eluting stent","volume":"15","author":"Kobo","year":"2019","journal-title":"Future Cardiol"},{"issue":"9","key":"10.1016\/j.carrev.2019.12.039_bb0160","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jcin.2016.02.044","article-title":"Biodegradable-polymer Sirolimus-eluting stents versus durable-polymer Everolimus-eluting stents in patients with acute ST-segment elevation myocardial infarction: insights from the 2-year follow-up of the BIOSCIENCE trial","volume":"9","author":"Piccolo","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.carrev.2019.12.039_bb0165","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/17434440.2017.1378091","article-title":"Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives","volume":"14","author":"Iglesias","year":"2017","journal-title":"Expert Rev Med Devices"},{"issue":"10","key":"10.1016\/j.carrev.2019.12.039_bb0170","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.118.007331","article-title":"Subgroup analysis comparing ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in acute coronary syndrome patients","volume":"11","author":"Roguin","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.carrev.2019.12.039_bb0175","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4244\/EIJ-D-17-00734","volume":"14","author":"Iglesias","year":"2018","journal-title":"EuroIntervention"},{"issue":"10205","key":"10.1016\/j.carrev.2019.12.039_bb0180","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0140-6736(19)31877-X","article-title":"Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial","volume":"394","author":"Iglesias","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.carrev.2019.12.039_bb0185","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcin.2018.01.228","article-title":"The top papers of 2017: by subsequent citations and online views and downloads","volume":"11","author":"Moliterno","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.carrev.2019.12.039_bb0190","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/MCA.0000000000000470","article-title":"Angiographic and clinical outcomes after recanalization of coronary chronic total occlusions with the Orsiro sirolimus-eluting stent compared with the resolute zotarolimus-eluting stent","volume":"28","author":"Markovic","year":"2017","journal-title":"Coron Artery Dis"},{"issue":"7","key":"10.1016\/j.carrev.2019.12.039_bb0195","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.carrev.2016.04.002","article-title":"Optical coherence tomography findings after chronic total occlusion interventions: insights from the \u201cAngiographiC evaluation of the everolimus-eluting stent in chronic total occlusions\u201d (ACE-CTO) study (NCT01012869)","volume":"17","author":"Sherbet","year":"2016","journal-title":"Cardiovasc Revasc Med"},{"issue":"2","key":"10.1016\/j.carrev.2019.12.039_bb0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcin.2016.10.017","article-title":"Randomized multicenter trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions: the PRISON IV trial","volume":"10","author":"Teeuwen","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"10.1016\/j.carrev.2019.12.039_bb0205","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jcin.2019.05.044","article-title":"3-year clinical outcomes of the PRISON-IV trial: ultrathin struts versus conventional drug-eluting stents in total coronary occlusions","volume":"12","author":"Zivelonghi","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.carrev.2019.12.039_bb0210","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/joic.12516","article-title":"Impact of ultra-thin struts on restenosis after chronic total occlusion recanalization: insights from the randomized PRISON IV trial","volume":"31","author":"Zivelonghi","year":"2018","journal-title":"J Interv Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2019.12.039_bb0215","doi-asserted-by":"crossref","DOI":"10.4244\/EIJ-D-17-00261","volume":"13","author":"Teeuwen","year":"2017","journal-title":"EuroIntervention"},{"issue":"13","key":"10.1016\/j.carrev.2019.12.039_bb0220","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.4244\/EIJ-D-17-00731","article-title":"Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial)","volume":"13","author":"Jensen","year":"2018","journal-title":"EuroIntervention"},{"issue":"4","key":"10.1016\/j.carrev.2019.12.039_bb0225","first-page":"567","article-title":"Impact of diabetes on clinical outcomes after revascularization with sirolimus-eluting and biolimus-eluting stents with biodegradable polymer from the SORT OUT VII trial","volume":"93","author":"Ellert","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.carrev.2019.12.039_bb0230","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/heartjnl-2013-304933","article-title":"Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography","volume":"100","author":"Cassese","year":"2014","journal-title":"Heart"},{"issue":"8","key":"10.1016\/j.carrev.2019.12.039_bb0235","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008024","article-title":"Long-term effect of ultrathin-strut versus thin-strut drug-eluting stents in patients with small vessel coronary artery disease undergoing percutaneous coronary intervention","volume":"12","author":"Iglesias","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.carrev.2019.12.039_bb0240","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/jamacardio.2019.1776","article-title":"Outcomes in patients treated with thin-strut, very thin-strut, or ultrathin-strut drug-eluting stents in small coronary vessels: a Prespecified analysis of the randomized BIO-RESORT trial","volume":"4","author":"Buiten","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.carrev.2019.12.039_bb0245","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4244\/EIJ-D-17-01079","article-title":"Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trial","volume":"14","author":"Jensen","year":"2018","journal-title":"EuroIntervention"},{"issue":"12","key":"10.1016\/j.carrev.2019.12.039_bb0250","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.5603\/KP.2018.0228","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"76","author":"Neumann","year":"2018","journal-title":"Kardiol Pol"},{"issue":"9","key":"10.1016\/j.carrev.2019.12.039_bb0255","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.carrev.2018.11.006","article-title":"Health economic evaluation of an ultrathin, bioresorbable-polymer sirolimus-eluting coronary stent compared to a thin, durable-polymer everolimus-eluting stent","volume":"20","author":"Mattke","year":"2019","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2019.12.039_bb0260","series-title":"American College of Cardiology (ACC 19)","article-title":"Two-year results after implantation of an ultrathin, bioresorbable polymer sirolimus-eluting coronary stent compared with a thin, durable polymer everolimus-eluting stent: Health economic evaluation","year":"2019"},{"issue":"3","key":"10.1016\/j.carrev.2019.12.039_bb0265","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1377\/hlthaff.2016.1627","article-title":"National health expenditure projections, 2016\u201325: price increases, aging push sector to 20 percent of economy","volume":"36","author":"Keehan","year":"2017","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.carrev.2019.12.039_bb0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2018.04.019","volume":"202","author":"Jakobsen","year":"2018","journal-title":"Am Heart J"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920300099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838920300099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:16:47Z","timestamp":1761560207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838920300099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1553838920300099"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.12.039","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Orsiro Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stent: A Review of Current Evidence","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.12.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}